HeartFlow, Inc.

About HeartFlow, Inc.

HeartFlow, Inc. is a medical technology company that develops AI-driven diagnostic solutions for coronary artery disease, the leading cause of death worldwide. The company's flagship product, HeartFlow FFRCT Analysis, is a non-invasive cardiac test that generates a color-coded 3D model of a patient's coronary arteries to assess blood flow blockages, and is supported by ACC/AHA Chest Pain Guidelines. HeartFlow's integrated heart care solution includes RoadMap™ Analysis for identifying stenoses, FFRCT Analysis for assessing coronary blood flow, and Plaque Analysis for characterizing atherosclerosis. As a publicly traded company (HTFL), HeartFlow has achieved international recognition in healthcare innovation and is cleared for use across the US, UK, Europe, Japan, and Canada, with its technology deployed in over 750,000 patient cases worldwide.